최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기Biochemical pharmacology, v.175, 2020년, pp.113920 -
Lee, Yu-Jin (Laboratory of Chemical Biology and Genomics, Korea Research Institute of Bioscience and Biotechnology) , Song, Harim (Laboratory of Chemical Biology and Genomics, Korea Research Institute of Bioscience and Biotechnology) , Yoon, Yae Jin (Laboratory of Chemical Biology and Genomics, Korea Research Institute of Bioscience and Biotechnology) , Park, Seung-Jin (University of Science and Technology in Korea) , Kim, Seon-Young (University of Science and Technology in Korea) , Cho Han, Dong (Laboratory of Chemical Biology and Genomics, Korea Research Institute of Bioscience and Biotechnology) , Kwon, Byoung-Mog (Laboratory of Chemical Biology and Genomics, Korea Research Institute of Bioscience and Biotechnology)
Abstract To identify signal transducer and activator of transcription factor 3 (STAT3) inhibitors, we generated STAT3-dependent gene expression signature by analyzing gene expression profiles of DU145 cancer cells treated with STAT3 inhibitor, piperlongumine and 2-hydroxycinnamaldehyde. Then we exp...
N. Engl. J. Med. Dvorak 315 1650 1986 10.1056/NEJM198612253152606 Tumors wounds that do not heal. Similarities between tumor stroma generation and wound healing
PLoS Biol. Chang 2 E7 2004 10.1371/journal.pbio.0020007 Gene expression signature of fibroblast serum response predicts human cancer progression: similarities between tumors and wounds
Cell Hanahan 144 646 2011 10.1016/j.cell.2011.02.013 Hallmarks of cancer: the next generation
J. Clin. Invest. Chen 125 3384 2015 10.1172/JCI80011 Anti-PD-1/PD-L1 therapy of human cancer: past, present, and future
Cell Cycle Shaw 9 4294 2010 10.4161/cc.9.21.13677 Could STAT3 provide a link between respiration and cell cycle progression?
Cell Res. Liu 28 996 2018 10.1038/s41422-018-0080-0 STAT3 associates with vacuolar H(+)-ATPase and regulates cytosolic and lysosomal pH
Science Lamb 313 1929 2006 10.1126/science.1132939 The Connectivity Map: using gene-expression signatures to connect small molecules, genes, and disease
R. Soc. Open Sci. Liu 5 2018 10.1098/rsos.181321 Systematic polypharmacology and drug repurposing via an integrated L1000-based Connectivity Map database mining
Nat. Rev. Drug Discov. Pushpakom 18 41 2019 10.1038/nrd.2018.168 Drug repurposing: progress, challenges and recommendations
J. Clin. Invest. Goldberg 43 201 1964 10.1172/JCI104905 Effects of Ethacrynic Acid (a New Saluretic Agent) on Renal Diluting and Concentrating Mechanisms: Evidence for Site of Action in the Loop of Henle
Kid. Int. Burg 4 301 1973 10.1038/ki.1973.121 Effect of ethacrynic acid on the thick ascending limb of Henle's loop
Biochim. Biophys. Acta Awasthi 1164 173 1993 10.1016/0167-4838(93)90245-M Interactions of glutathione S-transferase-pi with ethacrynic acid and its glutathione conjugate
Eur. J. Pharm. Sci. Bezerra 48 453 2013 10.1016/j.ejps.2012.12.003 Overview of the therapeutic potential of piplartine (piperlongumine)
Phytoth. Res. Hong 30 754 2016 10.1002/ptr.5592 Cinnamaldehyde in cancer chemotherapy
Curr. Protoc. Chem. Biol. Lomenick 3 163 2011 10.1002/9780470559277.ch110180 Target identification using drug affinity responsive target stability (DARTS)
Oncogene Bharadwaj 34 1341 2015 10.1038/onc.2014.72 Drug-repositioning screening identified piperlongumine as a direct STAT3 inhibitor with potent activity against breast cancer
Cancer Sci. Yoon 110 366 2019 10.1111/cas.13852 2'-Hydroxycinnamaldehyde inhibits proliferation and induces apoptosis via signal transducer and activator of transcription 3 inactivation and reactive oxygen species generation
Biochem. Biophys. Res. Commun. Um 427 24 2012 10.1016/j.bbrc.2012.08.133 Withaferin A inhibits JAK/STAT3 signaling and induces apoptosis of human renal carcinoma Caki cells
Cancer Res. Shin 69 193 2009 10.1158/0008-5472.CAN-08-2575 Cryptotanshinone inhibits constitutive signal transducer and activator of transcription 3 function through blocking the dimerization in DU145 prostate cancer cells
Biochem. Pharmacol. Jung 97 38 2015 10.1016/j.bcp.2015.06.033 Sugiol inhibits STAT3 activity via regulation of transketolase and ROS-mediated ERK activation in DU145 prostate carcinoma cells
JAKSTAT Bohmer 3 2014 Protein tyrosine phosphatases as wardens of STAT signaling
Biochem. Biophys. Res. Commun. Yamamoto 297 811 2002 10.1016/S0006-291X(02)02291-X The nuclear isoform of protein-tyrosine phosphatase TC-PTP regulates interleukin-6-mediated signaling pathway through STAT3 dephosphorylation
J. Mol. Endocrinol. Lund 34 339 2005 10.1677/jme.1.01694 Mechanism of protein tyrosine phosphatase 1B-mediated inhibition of leptin signalling
Leukemia Han 20 1602 2006 10.1038/sj.leu.2404323 Restoration of shp1 expression by 5-AZA-2'-deoxycytidine is associated with downregulation of JAK3/STAT3 signaling in ALK-positive anaplastic large cell lymphoma
Hepatology Blechacz 50 1861 2009 10.1002/hep.23214 Sorafenib inhibits signal transducer and activator of transcription-3 signaling in cholangiocarcinoma cells by activating the phosphatase shatterproof 2
Mol. Cell Lu 8 759 2001 10.1016/S1097-2765(01)00369-0 Site-specific incorporation of a phosphotyrosine mimetic reveals a role for tyrosine phosphorylation of SHP-2 in cell signaling
J. Biol. Chem. Akasaki 281 6165 2006 10.1074/jbc.M505266200 A peroxisome proliferator-activated receptor-gamma agonist, troglitazone, facilitates caspase-8 and -9 activities by increasing the enzymatic activity of protein-tyrosine phosphatase-1B on human glioma cells
Biochem. Biophys. Res. Comm. Chiba 473 323 2016 10.1016/j.bbrc.2016.03.103 Serotonin suppresses b-casein expression via PTP1B activation in human mammary epithelial cells
Biochem. Pharmacol. Jin 142 46 2017 10.1016/j.bcp.2017.06.131 Geranylnaringenin (CG902) inhibits constitutive and inducible STAT3 activation through the activation of SHP-2 tyrosine phosphatase
Nature Chen 535 148 2016 10.1038/nature18621 Allosteric inhibition of SHP2 phosphatase inhibits cancers driven by receptor tyrosine kinases
Structure Barford 6 249 1998 10.1016/S0969-2126(98)00027-6 Revealing mechanisms for SH2 domain-mediated regulation of the protein tyrosine phosphatase SHP-2
Proc. Natl. Acad. Sci. U.S.A. Lomenick 106 21984 2009 10.1073/pnas.0910040106 Target identification using drug affinity responsive target stability (DARTS)
Nat. Rev. Cancer Yu 14 736 2014 10.1038/nrc3818 Revisiting STAT3 signalling in cancer: new and unexpected biological functions
Nat. Rev. Cancer Huynh 19 82 2019 10.1038/s41568-018-0090-8 Therapeutically exploiting STAT3 activity in cancer - using tissue repair as a road map
Cancer Sci. Jeon 106 413 2015 10.1111/cas.12608 Ginkgetin inhibits the growth of DU-145 prostate cancer cells through inhibition of signal transducer and activator of transcription 3 activity
Nat. Rev. Cancer Ostman 6 307 2006 10.1038/nrc1837 Protein-tyrosine phosphatases and cancer
Nat. Rev. Drug. Discov. Copeland 5 730 2006 10.1038/nrd2082 Drug-target residence time and its implications for lead optimization
Br. J. Pharmacol. Vauquelin 168 1771 2013 10.1111/bph.12106 Exploring avidity: understanding the potential gains in functional affinity and target residence time of bivalent and heterobivalent ligands
Science Savitski 346 1255784 2014 10.1126/science.1255784 Proteomics. Tracking cancer drugs in living cells by thermal profiling of the proteome
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.